Personalized monitoring of ambulatory function with a smartphone 2-minute walk test in multiple sclerosis
- PMID: 36755463
- PMCID: PMC10152211
- DOI: 10.1177/13524585231152433
Personalized monitoring of ambulatory function with a smartphone 2-minute walk test in multiple sclerosis
Abstract
Background: Remote smartphone-based 2-minute walking tests (s2MWTs) allow frequent and potentially sensitive measurements of ambulatory function.
Objective: To investigate the s2MWT on assessment of, and responsiveness to change in ambulatory function in MS.
Methods: One hundred two multiple sclerosis (MS) patients and 24 healthy controls (HCs) performed weekly s2MWTs on self-owned smartphones for 12 and 3 months, respectively. The timed 25-foot walk test (T25FW) and Expanded Disability Status Scale (EDSS) were assessed at 3-month intervals. Anchor-based (using T25FW and EDSS) and distribution-based (curve fitting) methods were used to assess responsiveness of the s2MWT. A local linear trend model was used to fit weekly s2MWT scores of individual patients.
Results: A total of 4811 and 355 s2MWT scores were obtained in patients (n = 94) and HC (n = 22), respectively. s2MWT demonstrated large variability (65.6 m) compared to the average score (129.5 m), and was inadequately responsive to anchor-based change in clinical outcomes. Curve fitting separated the trend from noise in high temporal resolution individual-level data, and statistically reliable changes were detected in 45% of patients.
Conclusions: In group-level analyses, clinically relevant change was insufficiently detected due to large variability with sporadic measurements. Individual-level curve fitting reduced the variability in s2MWT, enabling the detection of statistically reliable change in ambulatory function.
Keywords: Multiple sclerosis; ambulatory function; digital technology; outpatient monitoring; patient-specific modeling; smartphone.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: P.v.O. and F.d.G. are employees of Sherpa BV and Orikami Digital Health Products, respectively (industry partners). B.M.J.U. received consultancy fees from Biogen Idec, Genzyme, Merck Serono, Novartis, Roche, and Teva. J.K. has accepted speaker and consultancy fees from Merck, Biogen, Teva, Genzyme, Roche, and Novartis. The remaining authors have no conflicts of interest to declare.
Figures



References
-
- Heesen C, Böhm J, Reich C, et al.. Patient perception of bodily functions in multiple sclerosis: Gait and visual function are the most valuable. Mult Scler 2008; 14(7): 988–991. - PubMed
-
- Sutliff MH.Contribution of impaired mobility to patient burden in multiple sclerosis. Curr Med Res Opin 2010; 26(1): 109–119. - PubMed
-
- Scalfari A, Neuhaus A, Daumer M, et al.. Early relapses, onset of progression, and late outcome in multiple sclerosis. JAMA Neurol 2013; 70(2): 214–222. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical